Congrats to colleagues & partners with numerous presentations involving #suprach…
[ad_1]
Congrats to colleagues & partners with numerous presentations involving #suprachoroidal delivery at last week’s @OISTWEETS & #ASRS meetings!
In addition to FDA-approved #Xipere, 6 trials globally are assessing 4 different investigational therapies, using the SCS Microinjector. https://t.co/g8QZgV3Fp0
[ad_2]
Source by Thomas Ciulla, MD, MBA